Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 400Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Aucta Pharmaceuticals

02 6Pharmathen SA

03 6ABC Farmaceutici SpA

04 3Abdi Ibrahim

05 9Accord healthcare

06 6Actavis Inc

07 9Alembic Pharmaceuticals Limited

08 9Alkem Laboratories

09 18Alphapharm PTY Ltd

10 3Amneal Pharmaceuticals

11 6Annora Pharma

12 6Apotex Inc

13 18Arrotex Pharmaceuticals

14 2Ascend Labs

15 6Ascent Innovative Medicines

16 3Auro Pharma Inc

17 9Aurobindo Pharma Limited

18 2Aurovitas Spain, Sau

19 1Avenza Pharmaceuticals

20 2Bexal Farmaceutica Sa

21 3Bionpharma

22 3Chartwell Pharmaceuticals llc

23 6Cipla

24 3DOC Generici

25 3Farmatek

26 3GSK

27 5Glenmark Pharmaceuticals

28 3Inventia Healthcare Limited

29 3Jerome Stevens Pharmaceuticals

30 6Jubilant Generics

31 18Juno Pharmaceuticals Pty Ltd

32 4KMS Health Center

33 9MSN Laboratories

34 3Medical Valley

35 6Norvium

36 18Novartis Pharmaceuticals Australia Pty Limited

37 31Novartis Pharmaceuticals Corporation

38 5Novartis South Africa (Pty) Ltd

39 3ORIFARM GROUP AS

40 3PHARMOBEDIENT

41 36Pharmacore Inc

42 6Pharmascience Inc.

43 3Piramal Pharma Solutions

44 1Ratiopharm Espana Sa

45 6STADA Arzneimittel

46 30Sandoz B2B

47 9Sun Pharmaceutical Industries Limited

48 1Tarbis Farma Sl

49 6Taro Pharmaceutical Industries

50 18Teva Pharma Australia

51 18Teva Pharmaceutical Industries

52 9Torrent Pharmaceuticals Limited

53 3Umedica Laboratories

54 6Viatris

55 3Vivanta Generics Sro

56 4World Medicine

57 9Zentiva

58 6Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

Regulatory Info : RX

Registration Country : USA

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 90MG

Packaging :

Approval Date : 2021-03-09

Application Number : 214559

Regulatory Info : RX

Registration Country : USA

Aucta Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Deferasirox

Brand Name :

Dosage Form : Tablet

Dosage Strength : 90MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

Regulatory Info : RX

Registration Country : USA

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 180MG

Packaging :

Approval Date : 2021-03-09

Application Number : 214559

Regulatory Info : RX

Registration Country : USA

Aucta Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

Regulatory Info : RX

Registration Country : USA

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 360MG

Packaging :

Approval Date : 2021-03-09

Application Number : 214559

Regulatory Info : RX

Registration Country : USA

Aucta Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

Regulatory Info :

Registration Country : U.S.A

Deferasirox

Brand Name :

Dosage Form : Oral Granule

Dosage Strength : 360MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : U.S.A

Aucta Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Deferasirox

Brand Name :

Dosage Form : Tablet

Dosage Strength : 180MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Deferasirox

Brand Name :

Dosage Form : Tablet

Dosage Strength : 360MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : Authorized

Registration Country : Spain

Deferasirox

Brand Name : Deferasirox Pharmathen

Dosage Form : Film Coated Tablet

Dosage Strength : 360MG

Packaging :

Approval Date : 2022-04-21

Application Number : 86902

Regulatory Info : Authorized

Registration Country : Spain

Pharmathen

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : Authorized

Registration Country : Spain

Deferasirox

Brand Name : Deferasirox Pharmathen

Dosage Form : Film Coated Tablet

Dosage Strength : 180MG

Packaging :

Approval Date : 2022-04-19

Application Number : 86889

Regulatory Info : Authorized

Registration Country : Spain

Pharmathen

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : Authorized

Registration Country : Spain

Deferasirox

Brand Name : Deferasirox Pharmathen

Dosage Form : Film Coated Tablet

Dosage Strength : 90MG

Packaging :

Approval Date : 2022-04-21

Application Number : 86901

Regulatory Info : Authorized

Registration Country : Spain

Pharmathen

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 2016-01-26

Application Number : 203560

Regulatory Info : RX

Registration Country : USA

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2016-01-26

Application Number : 203560

Regulatory Info : RX

Registration Country : USA

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Deferasirox

Brand Name : Deferasirox Juno

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Deferasirox

Brand Name : Deferasirox Juno

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Deferasirox

Brand Name : Deferasirox Juno

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 2005-11-02

Application Number : 21882

Regulatory Info : RX

Registration Country : USA

blank

17

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2005-11-02

Application Number : 21882

Regulatory Info : RX

Registration Country : USA

blank

18

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2005-11-02

Application Number : 21882

Regulatory Info : RX

Registration Country : USA

blank

19

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Deferasirox

Brand Name : Pharmacor Deferasirox

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Deferasirox

Brand Name : Pharmacor Deferasirox

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank